Andrew Kaszpurenko serves as the Director of Advanced Analytics at Edwards Lifesciences, a leading company in medical technology, particularly in heart valve and critical care monitoring solutions. In this pivotal role, Andrew spearheads a talented team of analysts and data scientists, focusing on harnessing data-driven...
Andrew Kaszpurenko serves as the Director of Advanced Analytics at Edwards Lifesciences, a leading company in medical technology, particularly in heart valve and critical care monitoring solutions. In this pivotal role, Andrew spearheads a talented team of analysts and data scientists, focusing on harnessing data-driven insights to inform strategic decision-making across various departments, including Marketing, Sales, Clinical, and Investor Relations. His expertise in executive communication and C-suite presenting ensures that complex narratives are distilled into compelling presentations that resonate with senior leadership and stakeholders.
Andrew’s proficiency in machine learning and artificial intelligence, particularly with tools such as TensorFlow and XGBoost, empowers his team to develop predictive models that enhance medical claims analysis. By leveraging his extensive knowledge of medical coding systems, including CPT, ICD-10, and DRG, he effectively analyzes cost and utilization patterns, driving operational efficiencies and uncovering opportunities for innovation within the medical devices sector. His adeptness with programming languages like Python, utilizing libraries such as Pandas and NumPy, allows for sophisticated data manipulation and analysis, further enhancing the quality of insights generated.
Key projects under Andrew’s leadership have included the development of comprehensive slide decks that support critical narratives for executive leadership teams, ensuring that data-driven decisions are backed by robust analytical frameworks. His commitment to identifying and integrating diverse data sources, coupled with a strong foundation in project management and requirements analysis, positions him as a vital asset in advancing Edwards Lifesciences' mission to improve patient outcomes through innovative technology and analytics.
